send to a friend by email
2023-08-14
According to the financial statements of Birziet Pharmaceuticals Company BPC for the first half of 2023, Net profit after tax of the period reached 3,488,417 USD Compared with Net profit after tax 5,377,300 USD for 2022, a net decrease in profit of 35.13%.Total assets of the company reached 125,041,702 USD compared with total assets of 123,003,262 USD at the end of year 2022, a net increase of 1.66%.Total liabilities of the company reached 20,631,926 USD compared with total liabilities of 19,489,454 USD at the end of year 2022, a net increase of 5.86%. Net ownership equity of the company reached 104,409,776 USD (Including Non-Controlling Interests of 995,070 USD) compared with total owner equity of 103,513,808 USD (Including Non-Controlling Interests of 923,623 USD) at the end of year 2022, a net increase of 0.87%.
|
|